3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
6
Breast Neoplasms
5
Lymphoma, Large B-Cell, Diffuse
4
Small Cell Lung Carcinoma
3
Ovarian Neoplasms
3
Lymphoma, Mantle-Cell
3
Burkitt Lymphoma
3
Waldenstrom Macroglobulinemia
2
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Prostatic Neoplasms
2
Neuroblastoma
2
Multiple Myeloma
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Myeloid, Acute
2
Immunoblastic Lymphadenopathy
2
Advanced Solid Tumors
2
Advanced Malignancies
2
Sarcoma
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Oligodendroglioma
1
Neurofibrosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Mesothelioma
1
Lymphoma, T-Cell, Peripheral
1
Interventions
fludarabine phosphate
23
Peripheral Blood Stem Cell Transplantation
19
Whole-Body Irradiation
18
Mycophenolic Acid
16
Cyclophosphamide
15
Busulfan
15
Tacrolimus
14
Antilymphocyte Serum
14
Cyclosporine
11
Melphalan
10
Rituximab
9
Methotrexate
9
Etoposide
8
romidepsin
6
Flow Cytometry
6
Filgrastim
6
Vorinostat
5
Dexamethasone
5
thymoglobulin
4
fludarabine
4
Sirolimus
4
Granulocyte Colony-Stimulating Factor
4
Carboplatin
4
Calcium Dobesilate
4
Bexarotene
4
Alemtuzumab
4
Thiotepa
3
Therapeutics
3
Radiotherapy
3
Panobinostat
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, T-Cell, Cutaneous
×
MLN 8237
×
Clear all
No trials found.